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a b s t r a c t
Each skeletal muscle contains a ﬁxed ratio of fast and slow myoﬁbers that are distributed in a
stereotyped pattern to achieve a speciﬁc motor function. How myoﬁbers are speciﬁed during develop-
ment and regeneration is poorly understood. Here we address this question using transgenic reporter
mice that indelibly mark the myoﬁber lineages based on activation of fast or slow myosin. Lineage
tracing indicates that during development all muscles have activated the fast myosin gene Myl1, but not
the slow myosin gene Myh7, which is activated in all slow but a subset of fast myoﬁbers. Similarly, most
nascent myoﬁbers do not activateMyh7 during fast muscle regeneration, but the ratio and pattern of fast
and slow myoﬁbers are restored at the completion of regeneration. At the single myoﬁber level, most
mature fast myoﬁbers are heterogeneous in nuclear composition, manifested by mosaic activation of
Myh7. Strikingly, Myh7 is activated in a subpopulation of proliferating myoblasts that co-express the
myogenic progenitor marker Pax7. When induced to differentiate, the Myh7-activated myoblasts
differentiate more readily than the non-activated myoblasts, and have a higher tendency, but not
restricted, to become slowmyotubes. Together, our data reveal signiﬁcant nuclear heterogeneity within a
single myoﬁber, and challenge the conventional view that myosin genes are only expressed after
myogenic differentiation. These results provide novel insights into the regulation of muscle ﬁber type
speciﬁcation.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The skeletal muscle comprises 40% of the body mass and func-
tions to empower body movements and regulate systemic energy
metabolism (Karagounis and Hawley, 2010; Zierath and Hawley,
2004). The skeletal muscle is mainly composed of mature muscle
cells called myoﬁbers, and myoﬁber composition in each muscle is
heterogeneous, containing a mixture of slow and fast type myoﬁbers
(Wang et al., 2004). Based on the relative abundance of slow and fast
myoﬁbers, a muscle can either be classiﬁed as a slow or a fast muscle.
For example, the soleus (SOL) muscle is a slow muscle as it contains
mostly slow (or type I) myoﬁbers; and the extensor digitorum longus
(EDL) muscle is a fast muscle because its myoﬁbers are predominantly
fast (type II) (Waddell et al., 2010). The slow and fast myoﬁbers are
different in biochemical, structural and physiological properties
(Bassel-Duby and Olson, 2006). Onemain criterion to classify myoﬁber
types is based on the myosin heavy chain (Myh) isoform expression. In
this scenario, fast myoﬁbers can be further divided into type IIA, IIX
and IIB based on the expression of Myh2, Myh1 and Myh4 genes,
respectively (Chakkalakal et al., 2012). By contrast, type I slow
myoﬁbers uniquely express the Myh7 gene, encoding the β-myosin
heavy chain protein that is also expressed in cardiac muscles (Chen
and Wang, 2012). The contractile speed of these myoﬁbers ranks in
the order of IIB4IIX4IIA4I. Based on energy utilization, myoﬁbers
can also be classiﬁed as oxidative (I, IIA) and glycolytic (IIX, IIB)
myoﬁbers.
When skeletal muscles are damaged, they regenerate to rees-
tablish the preexisting myoﬁber types (Feldman and Stockdale,
1991). Satellite cells, a population of muscle resident stem cells,
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are responsible for the regeneration of injured muscles (Relaix and
Zammit, 2012). Satellite cells are quiescent in non-injured adult
muscles. In response to muscle injury, they are activated and
reenter the cell cycle to proliferate, then differentiate and fuse
with the damaged myoﬁbers to repair the damages (Kuang and
Rudnicki, 2008). Meanwhile, a subpopulation of the proliferating
myoblasts undergoes self-renewal to replenish the quiescent
satellite cell pool. The self-renewal, proliferation and differentia-
tion status of satellite cells can be distinguished by the expression
of Pax7 and MyoD, manifested as Pax7þ/MyoD , Pax7þ/MyoDþ
and Pax7/MyoDþ , respectively (Olguin and Olwin, 2004; Zammit
et al., 2004).
A long-standing unresolved question is whether myoﬁber speci-
ﬁcation occurs at the progenitor cell level (i.e. subpopulations of
progenitor cells give rise to fast and slow myoﬁbers, respectively) or
at the post-differentiation level (i.e. fast and slow myoﬁbers originate
from a common progenitor population). Nevertheless, it has been
widely accepted that Myh genes are only expressed in post-
differentiation muscle cells. In the present study, we conducted
genetic lineage analyses to determine the speciﬁcation of fast and
slow myoﬁbers during development and regeneration. As Myh7 and
Myl1 genes are unique markers of mature slow (type I) and fast (type
II) myoﬁbers, respectively, we used Myh7-Cre and Myl1-Cre mice, in
combination of ﬂuorescent reporter mice, to delineate if mature fast
and slow myoﬁbers originate from progenitors expressing the
corresponding myosin genes. Using this strategy, we show that
Myl1 gene is activated in all fast and slow myoﬁbers, but Myh7 is
only activated in a subset of fast myoﬁbers in addition to slow
myoﬁbers. Surprisingly, we found that Myh7 is activated in a subset
of actively proliferating myoblasts, thus challenging the previous
view that Myh genes are only activated in differentiated cells. When
induced to differentiate, the Myh7-activated myoblasts were not
limited to become slow myotubes, though they had a higher
tendency to do so. These results provide mechanistic insights into
muscle ﬁber type speciﬁcation.
Materials and methods
Animals
All procedures involving the use of animals were performed under
the guideline of Purdue University's Animal Care and Use Committee.
Mice were housed in animal facility with free access to water and
standard rodent chow. The reporter mice were purchased from
Jackson Laboratory (Bar Harbor, ME) under that stock numbers:
Rosa26-EYFP (Madisen et al., 2010), 007903; Rosa26-TdTomato
(Madisen et al., 2010), 007905; and Rosa26-mTmG (Muzumdar et
al., 2007), 007576. The Myh7-Cre transgenic mouse (Parsons et al.,
2004) was provided by Katherine Yutzey (Cincinnati Children's
Hospital Medical Center, Cincinnati, Ohio). The Myl1-Cre knockin
mouse (Bothe et al., 2000) was provided by Steven Burden (New York
University Medical Center, NY). The PCR genotyping was done using
protocols described by the supplier.
Cardiotoxin (CTX) injection
CTX (Sigma) was used to induce muscle regeneration. Mice
were anesthetized by IP injection of 0.1 ml ketamine cocktail per
10 g body weight and TA/EDL muscles were injected with 50 μl of
10 μM CTX. Muscles were embedded in optimal cutting tempera-
ture (OCT) compound (Sakura Finetek) and fresh-frozen in iso-
pentane chilled on dry ice. Frozen samples were cut into 10 μm
thickness sections on a CM1850 cryostat (Leica). Muscle sections
were collected on Superfrost Plus glass slides (Electron Microscopy
Sciences).
Immunostaining and imaging
Cryosections were thawed at room temperature and washed
with PBS to wash out the OCT. Samples were then blocked in PBS
containing 5% goat serum, 2% BSA, 0.2% triton X-100 and 0.1%
sodium azide. Primary antibodies used were anti-Pax7, anti-MYHC
I, anti-MYHC IIA, anti-MYHC IIB (Developmental Studies Hybri-
doma Bank, University of Iowa, Iowa City, IA, USA), anti-MyoD
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-Laminin
(Sigma-Aldrich, St. Louis, MO, USA). Samples were incubated in
primary antibodies diluted in blocking buffer for overnight at 4 1C,
followed by incubating with secondary antibodies and 40, 6-
diamidino-2-phenylindole (DAPI) diluted in PBS for 30 min at
room temperature. Cultured cells were ﬁxed by 4% PFA, and then
quenched by 100 nM Glycine, followed by similar staining steps.
Stained samples were mounted with Dako ﬂuorescent mounting
media (DAKO corp., Carpinteria, CA, USA). Fluorescent images were
captured with a Coolsnap HQ CCD camera (Photometrics, USA)
driven by IP Lab software (Scanalytics Inc, USA) using Leica
DMI6000B ﬂuorescent microscope (Leica Microsystems, Man-
nheim, Germany) with 1.25 , 10 , or 20 objectives.
Primary myoblast culture
Hindlimb muscles were collected and trimmed free of con-
nective tissues and tendons, minced with scissors and digested in
collagenase/dispase in 6-cm petri dishes at 37 1C for 24 min. The
digestion solution contained 1% collagenase B (Roche, Indianapo-
lis, IN, USA) and 2.4 U/ml dispase (Roche). The digestion was
stopped by adding 3 volume of Ham's F-10 medium (Multicell)
with 5% FBS and triturated, then centrifuged at 250g for 5 min
using an IEC CENTRA CL2 centrifuge (Thermo Electron Corpora-
tion). After centrifugation, the pellet was resuspended and ﬁltered
through 70 μm cell strainer to remove debris, and cells were
pelleted and grown in 10 cm collagen-coated dishes with 10 ml of
Ham's F-10 medium containing 20% FBS, 1% penicillin/streptomy-
cin (P/S) and 4 ng/ml bFGF at 37 1C and 5% CO2. The initial culture
was refreshed with 5 ml growth medium every 24 h and passaged
to a new collagen-coated dish after 72 h. During passages, cells
were treated with 0.25% trypsin and closely monitored. To remove
ﬁbroblasts, the trypsinization was stopped immediately when
most myoblasts are detached from the plate but before ﬁbroblasts
detach. Cells were fed with fresh medium every two days. Upon
conﬂuence, cells were induced to differentiate in DMEM (Sigma)
containing 2% horse serum and 1% P/S.
Isolation and culture of single myoﬁbers
Intact EDL and SOL muscles were dissected out by cutting both
tendons and digested in 0.2% type I collagenase (Sigma) in DMEM
at 37 1C with agitation for 30 min (EDL muscle) or 70 min (SOL
muscle) until ﬁbers began to detach from the muscle. After
digestion, muscles were triturated with polished glass Pasteur
pipettes to liberate myoﬁbers from the collagenase loosened EDL
and SOL muscles. All pipettes and petri dishes were pre-rinsed
with horse serum to prevent myoﬁber attachment. Single myoﬁ-
bers were either directly ﬁxed or cultured in DMEM containing
20% FBS, 1% P/S, 0.5% Chicken Embryo Extract (CEE).
Statistical analysis
All data are presented as mean7standard deviation (SD). The
“n” in the results represents biological replicates unless speciﬁed.
At least three technical replicates were usually conducted within
each biological sample and the averaged value was used. For the
signiﬁcance analysis, two-tailed student's t-test was used to
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calculate the P values. If the P value is less than 0.05, then data are
considered as statistically signiﬁcant.
Results
Activation of Myh7 and Myl1 genes during muscle development
To investigate the progeny of Myh7-lineage myoﬁbers in “fast”
and “slow” muscles of adult mice, we established Myh7-Cre/
Rosa26-EYFP(or TdT) reporter mice in which myoﬁbers that have
once activated the Myh7 promoter were indelibly labeled by EYFP
or TdTomato (TdT, a red ﬂuorescent protein). To evaluate the
speciﬁcity of the Myh7-Cre, we examined developing somites and
limbbuds of Myh7-Cre/Rosa26-TdT mice. All cells labeled by the
Myh7 monoclonal antibody were also TdTþ , and 71% of TdTþ cells
were Myh7þ(Supplementary Fig. S1). This result suggests that
Myh7-Cre sufﬁciently marks all cells that concurrently express
Myh7 but additionally marks some cells that have undetectable
amounts of Myh7 protein. These Myh7-Cre marked myoblasts that
had undetectable levels of Myh7 protein may have activated the
Myh7 promoter without leading to protein synthesis (Refer to
Discussion).
At two months old, all myoﬁbers in the SOL muscle of Myh7-Cre/
Rosa26-EYFP mice were EYFPþ , but only 38% myoﬁbers in the EDL
muscle were EYFPþ (Fig. 1A). To conﬁrm the concurrent expression
of myosin in SOL and EDL muscles, we stained serial sections from
the same muscles with Myh7 and MY32 antibodies that react with
slow and fast Myh, respectively. There were 46% Myh7þ myoﬁbers in
the SOL muscles, but only 2% Myh7þ myoﬁbers in the EDL muscles,
the rest being MY32þ (Fig. 1B). These results suggest that many
mature fast myoﬁbers have expressed Myh7 during development. To
further address which subtype of fast myoﬁbers have historically
activated Myh7, cohort of serial muscle sections were stained with
monoclonal antibodies speciﬁcally recognize type I, type IIA and type
IIB Myh, and the unlabeled myoﬁbers were presumably type IIX. In
the SOL muscle, there were 46% type I, 48% type IIA and 6% type IIX
(and 0% IIB) myoﬁbers (Fig. 1C). By contrast, EDL muscles had 72%
type IIB, 13% type IIX, 13% type IIA and 2% type I myoﬁbers (Fig. 1C).
Co-localization with EYFP signal indicates that 100% type I, 100% type
IIA, 97% type IIX and 14% type IIB myoﬁber have activated the Myh7
(Supplementary Fig. S2). Similar activation pattern of Myh7 was
observed in TA muscles (data not shown). These results indicate that
mature type I and a subset of type II (primarily IIA and IIX) myoﬁbers
had activated Myh7 gene expression during development.
In parallel, we established Myl1-Cre/Rosa26-TdTomato mice to
speciﬁcally label myoﬁbers that have activated Myl1 in red
ﬂuorescence (TdT). All myoﬁbers examined in various muscles
were TdTþ (Supplementary Fig. S3). This observation suggests that
even though Myl1 is only concurrently expressed by fast myoﬁbers
in adults, it has also been activated in adult slow myoﬁbers during
development.
Activation of Myh7 during muscle regeneration
To investigate the activation pattern of Myh7 during regenera-
tion, we analyzed YFP expression and myoﬁber type distribution
after CTX induced muscle regeneration in Myh7-Cre/Rosa26-EYFP
mice. EDL muscles were injected with 50 μl CTX; the contralateral
undamaged EDL muscles were used as control. The CTX treatment
caused widespread degeneration of myoﬁbers in the EDL muscles,
followed by satellite cell mediated muscle regeneration. EDL
muscle samples were collected at 5 and 14 days post CTX injection
(dpi). At 5 dpi, there were 40% EYFPþ myoﬁbers in the non-
injured EDL muscles, but there were only 10% EYFPþ myoﬁbers
in the CTX treated EDL muscles (Fig. 2). Interestingly, no EYFPþ
myoﬁber were found in the injured area (left bottom area in the
ﬁrst column of Fig. 2). The regenerating myoﬁbers in the injured
area were MY32þ but were Myh4 and Myh7 (Fig. 2, ﬁrst
column), suggesting that these regenerating myoﬁbers express
Myh1, Myh2, or Myh8 (perinatal Myh).
At 14 dpi, there were still only 10% EYFPþ myoﬁbers in the CTX
injured muscles, compared to 40% EYFPþ myoﬁbers in the contral-
ateral non-injured muscles (Fig. 2). Besides type I myoﬁbers, EYFP can
only be found in uninjured type II myoﬁbers, which are distinguished
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from regenerated myoﬁbers by the lack of central nuclei. Surprisingly,
very few regenerated type II myoﬁbers, marked by central nuclear and
MY32þ , had EYFP expression, suggesting that most regenerated type
II myoﬁbers have not activated Myh7 at this stage. Interestingly,
centronucleated regenerating myoﬁbers coexpressing Myh7 and
MY32 were also identiﬁed, suggesting that some newly regenerated
type II myoﬁbers begun to switch to type I myoﬁber at this stage
(Supplementary Fig. S4). Together, these results demonstrate that
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Fig. 2. Myh7 activation and fast/slow myosin expression during regeneration of EDL muscles. EDL muscles of Myh7-Cre/Rosa26-EYFP mice were injured with CTX and
analyzed at 5 and 14 days postinjury. Top panels: muscle sections stained with EYFP and laminin (Lam). Middle panels: muscle sections stained with Myh7, MY32, and Lam
antibodies showing the distribution of slow and fast ﬁber types. Bottom panels: muscle sections stained with Myh7, Myh2, and Myh4 antibodies showing the distribution of
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Myh7 gene is not activated during muscle regeneration and type I
myoﬁbers in regenerated muscles directly emerge from existing type II
myoﬁbers.
Heterogeneous origin of myonuclei within a single myoﬁber
During skeletal muscle development, myoblasts fuse to form
multinuclear myotubes, which mature into myoﬁbers (Millay et al.,
2013). Each mature myoﬁber primarily expresses one myosin
subtype, but it is unknown if all myonuclei within a myoﬁber
express the same myosin subtype. To address this question, we
established the Myh7-Cre/Rosa26-mTmG reporter mice in which
cells that have once activated the Myh7 promoter are labeled by
membrane-targeted GFP, while other cells express membrane-
targeted RFP. The membrane-targeting strategy allows for visua-
lizing nuclear domainal mosaics in multinuclear myoﬁbers. Single
myoﬁbers were collected from SOL and EDL muscles and the
expression of GFP and RFP were examined. Most single myoﬁbers
isolated from SOL muscles were homogeneously green (Fig. 3A),
indicating that all myonuclei within these myoﬁbers had activated
Myh7. In contrast, many EDL myoﬁbers had mosaic expression of
GFP and RFP (Fig. 3A), suggesting heterogeneous contribution of
both Myh7 activated and non-activated myonuclei to these myo-
ﬁbers. Notably, most mosaic myoﬁbers predominantly express GFP
or RFP, with complementary expression of RFP or GFP at one end
of the myoﬁbers (Fig. 3A). Quantitative analysis indicates that SOL
myoﬁbers contains approximately 90% of pure GFPþ myoﬁbers
and 10% of mosaic GFPþ/RFPþ myoﬁbers (Fig. 3B). In contrast, EDL
myoﬁbers contains roughly 75% mosaic GFPþ/RFPþ myoﬁbers,
20% pure RFPþ myoﬁbers and 5% pure GFPþ myoﬁbers (Fig. 3B).
This observation suggest that EDL and SOL myonuclei were
apparently different in Myh7 activation, and even myonuclei
within a single myoﬁber can be heterogeneous in developmental
origin or myosin gene expression.
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Activation of Myh7 gene in a population of proliferating myoblasts
Myosin heavy chain genes are known to be expressed only in
differentiated myocytes that have exited cell cycle. Surprisingly, we
found that some primary myoblasts derived from Myh7-Cre/Rosa26-
mTmG mice exhibited GFP ﬂuorescence under growth conditions,
prior to induced differentiation (Supplementary Fig. S5). The GFPþ
myoblasts were more abundant in cultures derived from the slow
SOL muscles than in cultures derived from the fast EDL muscles
(Supplementary Fig. S5). To directly characterize Myh7 activation in
myoblasts, we isolated YFPþ and YFP myoblasts from Myh7-Cre/
Rosa26-EYFP mice using ﬂuorescence-activated cell sorting (FACS)
(Fig. 4A). About 20% of the myoblasts were gated as YFPþ (R3) and
the remainder myoblasts were YFP (Fig. 4A). After cultured for 1–4
days, the YFPþ and YFP myoblasts both expanded to similar
densities and were morphologically indistinguishable (Fig. 4B and
C). The sorted YFPþ myoblasts remained YFPþ during the culture
(Fig. 4B). Interestingly, a few EYFPþ cells (3%) emerged in the sor-
ted YFP myoblasts after cultured for 1 day, and the percentage
increased to 8% after 4 days (Fig. 4C), indicating de novo activation of
Myh7 during the culture. Importantly, the expansion of sorted YFPþ
cells in culture demonstrates that these Myh7-activated myoblasts
are proliferative and activation of Myh7 does not necessary mark
terminal differentiation.
To further characterize myogenic gene expression of the Myh7-
activated myoblasts, primary myoblasts from the Myh7-Cre/Rosa26-
EYFP mice were stained with Pax7 and MyoD antibodies. Although
most of the Pax7þ and MyoDþ myoblasts were YFP , some Pax7þ
and MyoDþ myoblasts were YFPþ (Fig. 5A). Overall, the relative
abundance of Pax7 and MyoD positive cells was not signiﬁcantly
different in the YFP and YFPþ myoblasts (Fig. 5A). As Pax7/MyoD
expression typically marks actively proliferating myoblasts, the co-
expression of Pax7 andMyoD in YFPþ cells indicates that these Myh7-
activated myoblasts are not differentiated myocytes. To conﬁrm this
notion, we next examined expression of the proliferation marker Ki67,
and detected Ki67þ cells in both YFP and YFPþ myoblasts (Fig. 5B).
However, there were signiﬁcantly more Ki67þ cells in YFP (30%)
than in YFPþ (15%) myoblasts (Fig. 5B). Consistently, low-density
cultures that allow clonal growth of individual myoblasts revealed that
Myh7-activated myoblasts formed smaller colonies than did the Myh7
non-activated myoblasts (Supplementary Fig. S6). Together, analysis of
Pax7, MyoD and Ki67 expression demonstrates that Myh7-activated
myoblasts are proliferative, but with reduced proliferative capacity
compared to myoblasts that had never activated Myh7.
Myh7 activation promotes but does not restrict differentiation
towards slow myotubes
To investigate the differentiation potential of Myh7-activated
myoblasts, we ﬁrst examined expression of the differentiation
marker myogenin (Fig. 5C). Interestingly, only a fraction of Myh7-
activated myoblasts were myogeninþ . Although myogenin expres-
sion is detected in both YFPþ and YFP myoblasts, the percentage of
myogeninþ/YFPþ cells was three times as many as the myogeninþ/
YFP cells (Fig. 5C). These results suggest that Myh7-activated
myoblasts are more readily primed for differentiation.
We next examined if activation of Myh7 programs myoblasts to
differentiate into corresponding slow myotubes. YFP and YFPþ
myoblasts were sorted from Myh7-Cre/Rosa26-EYFP mice, then
induced to differentiate by serum withdrawal. Both YFP and YFPþ
myoblasts fused to form multinuclear myotubes after 3 days of
differentiation (Fig. 6). However, the YFPþ myoblasts formed myo-
tubes more robustly than the YFP myoblasts (Fig. 6), again indicating
that Myh7-activated myoblasts differentiate more readily. Further-
more, analysis of myoﬁber type using MY32 and MF20 antibodies
reveal that whereas the YFP myoblasts predominantly formed
MY32þ (fast) myotubes, the YFPþ myoblasts formed both MY32þ
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Fig. 5. Myh7 activation in cultured primary myoblasts isolated from Myh7-Cre/Rosa26-EYFP mice. (A) Triple staining with GFP, Pax7, and MyoD antibodies. (B) Double
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(fast) and MY32 (slow) myotubes (Fig. 6). Collectively, activation of
Myh7 in myoblasts accelerated their differentiation, though they were
not restricted to become either slow or fast myotubes.
Discussion
Our studies uncovered several novel features of myosin gene
activation and myoﬁber speciﬁcation. We show that the fast
myosin gene Myl1 is activated in all adult fast and slow myoﬁbers.
In contrast, the slow myosin gene Myh7 is only activated in type I,
IIA and IIX myoﬁbers, and a small subset of IIB myoﬁbers.
Interestingly, even myonuclei within a single myoﬁber can be
highly heterogeneous in the activation of Myh7, suggesting their
mosaic origin. Combining lineage labeling and cell culture, we ﬁnd
that Myh7 is activated in a subpopulation of proliferating myo-
blasts, and Myh7 activation primes, but not restricts, their differ-
entiation towards slow myotubes.
Skeletal muscle myosin is consisted of two heavy (Myh) chains
and two light (Myl) chains (Schiafﬁno and Reggiani, 2011). The
essential and regulatory subunits of Myl also contain fast and slow
muscle speciﬁc isoforms. Myl1 is reported to be only expressed in
fast skeletal muscle ﬁbers in the adult (Bicer and Reiser, 2004;
Schiafﬁno and Reggiani, 1996; Timson, 2003), but its activation
during development is unknown. The ubiquitous labeling of all
adult fast and slow myoﬁbers by the Myl1-Cre knockin mouse
demonstrates that Myl1 is activated in all myoﬁbers during
development. This result further suggests that the Myl1-Cre
mouse may be served as an excellent driver for Cre/LoxP-
mediated, skeletal muscle-speciﬁc activation or inactivation of
target genes. Previously studies have predominantly used MCK-
Cre and HSA-Cre for muscle speciﬁc gene expression. However,
both strains are generated using transgenic promoter constructs,
therefore bear risks of non-faithful leaky expression in non-muscle
cells. In addition, the MCK-Cre also drives LoxP recombination in
cardiac muscle cells (Perdomini et al., 2014), and is thus not
skeletal muscle-speciﬁc.
The Myh7-Cre transgenic mouse has previously been used to
driven gene deletion or expression in cardiac muscles (Colbert
et al., 1997; Parsons et al., 2004), but its activation pattern in
Fig. 6. Differentiation of Myh7-activated and non-activated myoblasts. Myoblasts fromMyh7-Cre/Rosa26-EYFP mice were sorted based on YFPþ and YFP and differentiated
for 3 days. Differentiated myotubes (MF20þ) were then stained with GFP, MY32, and MF20 antibodies. GFP staining was used to enhance YFP signal to conﬁrm Myh7
activation or lack of Myh7 activation in the sorted YFPþ and YFP cells after differentiation. MY32 signaling indicates expression of fast myosin heavy chain and MF20 signal
indicates pan-sarcomeric myosin heavy chain. MY32/MF20þ myotubes thus express only slow myosin heavy chain. DAPI labels the nuclei. Scale bar: 50 μm.
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skeletal muscles is unclear. The observation that all Myh7 immu-
noreative cells in developing somites are marked by the Myh7-Cre
suggests that Myh7-Cre is sufﬁcient to drive slowmyoﬁber speciﬁc
gene expression. Additionally, 30% of Myh7-Cre marked cells in
the somites did not express Myh7 protein, suggesting that Myh7-
Cre transgene activation does not necessarily correspond to
detectable levels of Myh7 mRNA and protein. This may be due to
microRNA-mediated mRNA degradation or suppression of protein
translation (van Rooij et al., 2009). Alternatively, we cannot rule
out the possibility that the Myh7-Cre transgene may ectopically
activate the Rosa26-EYFP reporter in a small fraction of proliferat-
ing myoblasts. Future studies using Myh7Cre knockin allele will
distinguish these possibilities.
Using the Rosa26-EYFP reporter, we found that all myoﬁbers in
the SOL muscle of adult mice had activated Myh7-Cre but only about
half of the myoﬁbers concurrently express Myh7. Similarly, about 40%
of EDL myoﬁbers had activated Myh7, but only a few of these
myoﬁbers concurrently express the Myh7 protein. Further analysis
indicates that activation of Myh7-Cre in the EDL muscle mostly
occurs in the type IIA and IIX myoﬁbers. Interestingly, Myh7 is not
activated in newly regenerated EDL myoﬁbers, suggesting that
Myh7-activation in type IIA and IIX myoﬁbers occurs during myoﬁ-
ber maturation. As myoﬁber speciﬁcation during muscle regenera-
tion recapitulate that during embryonic myogenesis (Cerny and
Bandman, 1987), our results further suggest that slow myosin gene
activation occurs after fast myosin gene activation in a subset of fast
myoﬁbers during growth and development.
Single ﬁber analysis using Myh7-Cre/Rosa26-mTmG mice that
express membrane-targeted ﬂuorescent proteins (mGFP and
mRFP) reveals surprising heterogeneity in nuclear composition
with a single myoﬁber. While SOL myoﬁbers (containing 94% type I
and IIA ﬁbers) uniformly exhibit mGFP ﬂuorescence, EDL myoﬁ-
bers (containing 85% type IIX and IIB ﬁbers) mostly exhibit mosaic
mGFP and mRFP ﬂuorescence. This could have been resulted from
several different possibilities (Fig. 7). It is possible that during
development Myh7 non-activated myoblasts fuse to form uniform
mRFPþ myotubes, but a subset of the fused myotubes subse-
quently activate Myh7, therefore turning domains of the corre-
sponding membrane into mGFPþ (Fig. 7A). This notion is
supported by our results showing that during EDL muscle regen-
eration no nascent myotubes have activated the Myh7-Cre trans-
gene and Myh7 protein is subsequently expressed in a subset of
fast myoﬁbers during maturation. Alternatively, heterogeneous
Myh7-activated and non-activated myoblasts may fuse to form
myotubes exhibiting mosaic mRFP/mGFP expression pattern, and
the pattern is maintained during maturation (Fig. 7B). The uniform
mGFP ﬂuorescence in SOL myoﬁbers suggests that these myoﬁbers
are fused from myoblasts that have activated Myh7. However, our
model cannot exclude the possibility that a subset of myonuclei
subsequently turn off Myh7 expression and turn on fast myosin
expression during maturation (Fig. 7C).
Activation of Myh7 in a subset of actively proliferating myo-
blasts is surprising, as it has been believed that myosin gene
expression is only activated in differentiated myocytes (Abmayr
and Pavlath, 2012; Pajcini et al., 2010). During the culture of
myoblasts from Myh7-Cre/Rosa26-EYFP mice, we observed mono-
nuclear YFPþ cells whose number increases with time. This
suggests that either the YFPþ cells were proliferating or sponta-
neous differentiation of a subset of myoblasts under growth
conditions. When the YFPþ cells were puriﬁed by FACS, they
expanded robustly in culture, suggesting that they are prolifera-
tive. This is conﬁrmed by Ki67 expression in the YFPþ cells. The
undifferentiated status of the YFPþ cells is conﬁrmed by their
expression of the myogenic progenitor marker Pax7. Double
staining of Pax7 and Myh7 in developing somites indicates that
99% Pax7þ cells are Myh7(Supplementary Fig. S7), suggesting
that the Myh7-activated proliferating myoblasts do not express
signiﬁcant levels of Myh7 protein. Thus, expression of Myh7
protein, but not activation of Myh7 gene (mRNA), marks myogenic
differentiation. Nevertheless, the Myh7-activated myoblasts differ-
entiated more readily and formed both slow and fast myotubes,
while the Myh7 non-activated myoblasts differentiated less efﬁ-
ciently and formed predominantly fast myotubes. Collectively,
activation of Myh7 in a subpopulation of myoblasts primes, but
does not restrict, these cells to become slow myoﬁbers. This
observation is consistent with our recent analysis of porcine
myoblast differentiation (Zhu et al., 2013).
These results enhance our understanding of myosin gene
activation and myoﬁber speciﬁcation during development and
regeneration. Such knowledge may lead to novel strategies to
modify or diversify ﬁber type composition in the skeletal muscles,
and opportunities to improve athletic performance, prevent mus-
cle wasting in muscular dystrophy patients (in which type II
myoﬁbers are preferentially wasted) and enhancing meat quality
in agriculture.
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